Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells
Four platinum(IV) prodrugs incorporating a biotin moiety to selectively target cancer cells were synthesised, characterised, and their biological activity assessed. All complexes exhibited exceptional in vitro cytotoxicity against a panel of cancer cell lines, with [Pt(5,6-dimethyl-1,10-phenanthroli...
Main Authors: | Aleen Khoury, Jennette A. Sakoff, Jayne Gilbert, Shawan Karan, Christopher P. Gordon, Janice R. Aldrich-Wright |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/12/2780 |
Similar Items
-
Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
by: Aleen Khoury, et al.
Published: (2022-04-01) -
Potent Chlorambucil-Platinum(IV) Prodrugs
by: Angelico D. Aputen, et al.
Published: (2022-09-01) -
cGAS‐STING Pathway Activation and Systemic Anti‐Tumor Immunity Induction via Photodynamic Nanoparticles with Potent Toxic Platinum DNA Intercalator Against Uveal Melanoma
by: Hui Tao, et al.
Published: (2023-11-01) -
Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity
by: Angelico D. Aputen, et al.
Published: (2024-02-01) -
Determination of biotin content in beet molasses by Lactobacillus plantarum
by: Lončar Eva S., et al.
Published: (2005-01-01)